TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Nordic Pharma Inc AS
Closing information (x1000 NOK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
282,611
|
260,597
|
196,244 |
| Financial expenses |
24,416
|
42,855
|
44,654 |
| Earnings before taxes |
53,375
|
33,874
|
42,325 |
| Total assets |
503,593
|
460,408
|
455,527 |
| Current assets |
220,891
|
157,707
|
157,119 |
| Current liabilities |
38,128
|
25,081
|
28,348 |
| Equity capital |
330,173
|
288,469
|
262,051 |
| - share capital |
27,908
|
27,908
|
27,908 |
| Employees (average) | 39 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
65.6%
|
62.7%
|
57.5% |
| Turnover per employee | 7,246 | ||
| Profit as a percentage of turnover |
18.9%
|
13.0%
|
21.6% |
| Return on assets (ROA) |
15.4%
|
16.7%
|
19.1% |
| Current ratio |
579.3%
|
628.8%
|
554.3% |
| Return on equity (ROE) |
16.2%
|
11.7%
|
16.2% |
| Change turnover |
22,014
|
64,353
|
21,224 |
| Change turnover % |
8%
|
33%
|
12% |
| Chg. No. of employees | |||
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.